KAITLIN THORSON: Open Payments
NPI 1114591336 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,229 in 122 payments from 21 companies in 2025. Trend: 2023 $1,977 · 2024 $1,382 · 2025 $2,229
Food & beverage: $2,229
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $335 |
| Lilly USA, LLC | 13 | $226 |
| Novartis Pharmaceuticals Corporation | 11 | $207 |
| Novo Nordisk Inc | 12 | $202 |
| PFIZER INC. | 15 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $162 |
| Janssen Biotech, Inc. | 6 | $140 |
| Vantive US Healthcare LLC | 1 | $136 |
| ANI Pharmaceuticals, Inc. | 4 | $89 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
Products named: MOUNJARO, AIRSUPRA, LEQVIO, TREMFYA, Renal - Acute, NURTEC ODT, OTEZLA, EVENITY.
Industry payments across MO — which companies pay providers there.
